© 2021 MJH Life Sciences and Contemporary Clinic. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary Clinic. All rights reserved.
June 13, 2017
Patients with type 2 diabetes taking alirocumab (Praluent), along with the maximum tolerable dose of statins, saw a 49% drop in low-density lipoprotein cholesterol during a recent study.